FYCO1 has also been implicated in colorectal cancer progression (Sillars-Hardebol et al., 2010) and recent studies have concluded that FYCO1 may serve as a biomarker in bladder cancer (Eissa et al., 2017) or hepatocellular carcinoma (Vongchan and Linhardt, 2017; Figure 4C). Here, FYCO1 is linked to colorectal cancer.